Related references
Note: Only part of the references are listed.Lichen endophyte derived pyridoxatin inactivates Candida growth by interfering with ergosterol biosynthesis
Wenqiang Chang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans
Ying Li et al.
FEMS YEAST RESEARCH (2015)
Diorcinol D Exerts Fungicidal Action against Candida albicans through Cytoplasm Membrane Destruction and ROS Accumulation
Ying Li et al.
PLOS ONE (2015)
Update on antifungal resistance in Aspergillus and Candida
M. C. Arendrup
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery
Shuyuan Liu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Natural products: A continuing source of novel drug leads
Gordon M. Cragg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
The Monoamine Oxidase A Inhibitor Clorgyline Is a Broad-Spectrum Inhibitor of Fungal ABC and MFS Transporter Efflux Pump Activities Which Reverses the Azole Resistance of Candida albicans and Candida glabrata Clinical Isolates
Ann R. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Retigeric Acid B Enhances the Efficacy of Azoles Combating the Virulence and Biofilm Formation of Candida albicans
Wenqiang Chang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway
Chun-Yan Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Retigeric Acid B Attenuates the Virulence of Candida albicans via Inhibiting Adenylyl Cyclase Activity Targeted by Enhanced Farnesol Production
Wenqiang Chang et al.
PLOS ONE (2012)
Regulation of Efflux Pump Expression and Drug Resistance by the Transcription Factors Mrr1, Upc2, and Cap1 in Candida albicans
Sabrina Schubert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Differential Requirement of the Transcription Factor Mcm1 for Activation of the Candida albicans Multidrug Efflux Pump MDR1 by Its Regulators Mrr1 and Cap1
Selene Mogavero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Chung-Pu Wu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Functional Dissection of a Candida albicans Zinc Cluster Transcription Factor, the Multidrug Resistance Regulator Mrr1
Sabrina Schubert et al.
EUKARYOTIC CELL (2011)
Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Michaela Spitzer et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Bisbibenzyls, a New Type of Antifungal Agent, Inhibit Morphogenesis Switch and Biofilm Formation through Upregulation of DPP3 in Candida albicans
Li Zhang et al.
PLOS ONE (2011)
Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1
Ana B. Fernandez-Martinez et al.
CANCER LETTERS (2010)
Overexpression of CDR1 and CDR2 Genes Plays an Important Role in Fluconazole Resistance in Candida albicans with G487T and T916C Mutations
L. M. Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Efflux-Mediated Antifungal Drug Resistance
Richard D. Cannon et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Natural products - antifungal agents derived from plants
Tasleem Arif et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2009)
Screening and isolation of antinematodal metabolites against Bursaphelenchus xylophilus produced by fungi
Yanhui Zhu et al.
ANNALS OF MICROBIOLOGY (2008)
ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates
Ann R. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae
Min Huang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains
Nico Dunkel et al.
MOLECULAR MICROBIOLOGY (2008)
Outwitting multidrug resistance to antifungals
Brian C. Monk et al.
SCIENCE (2008)
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans
Joachim Morschhaeuser et al.
PLOS PATHOGENS (2007)
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections
Lixin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells
M. S. Spitzer et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
K Takara et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast
M Schuetzer-Muehlbauer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Natural products as sources of new drugs over the period 1981-2002
DJ Newman et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Dihydroisocoumarins and a tetralone from Cytospora eucalypticola
T Kokubun et al.
PHYTOCHEMISTRY (2003)
Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis et al.
LANCET (2002)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Targeted gene disruption in Candida albicans wild-type strains:: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates
S Wirsching et al.
MOLECULAR MICROBIOLOGY (2000)
Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
O Marchetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
